Log in to search using one of your social media accounts:

 

As a Buddhist Priest, Duke Neurosurgeon Finds Deeper Connection with Patients
Treatment TermsNeurosurgery Author Bryan Roth Overview Dr. Patrick Codd, MD, a Duke neurosurgeon, has been practicing Zen for two decades. The practice, he says, allows him to reflect on his work and relationships with patients and, ultimately, to deliver better care. Content Blocks Preview Image Featured Doctors and Providers Patrick J. Codd, MD Related Blog Posts 5 Minutes with Duke Neurosurgeon Oren Gottfried, MD Robot Reduces Need for Open Brain Surgery to Map Epileptic Seizures Deep brain stimulation surgery while asleep brings relief from dystonia BodyDisplay in Announcement Section:  Archived (Sou...
Source: dukehealth.org: Duke Health News - May 16, 2018 Category: Consumer Health News Authors: efh7 at duke.edu Source Type: news

INTREPID: New DBS System for Parkinson's Meets Endpoints INTREPID: New DBS System for Parkinson's Meets Endpoints
A new multiple-source system for deep-brain stimulation in patients with Parkinson's disease proved effective in the randomized, double-blind INTREPID trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 15, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Deep Brain Stimulation Affects the Activity of Hundreds of Genes
Changes in gene activity levels after DBS appear to underlie improvements seen in a mouse model of Rett syndrome, a genetic disease that causes intellectual disability. (Source: The Scientist)
Source: The Scientist - May 14, 2018 Category: Science Tags: Daily News,The Scientist Source Type: news

Report: Doctors warn that lightning can affect deep brain stimulation devices
Deep brain stimulation devices, used to treat neurological movement disorders like Parkinson’s disease, are vulnerable to strong electromagnetic fields that are created by other electrical devices. But when a 66-year-old Slovenian woman’s DBS implant stopped working, it wasn’t due to interference from a device – the malfunction was caused by lightning. In a case report published this week in the Journal of Neurosurgery, doctors described a unique case they encountered with a patient using a rechargeable DBS system to treat her neck dystonia. When her apartment was struck by lightning, the patie...
Source: Mass Device - May 4, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Neurological Source Type: news

Lightning Can Affect Deep Brain Stimulation Devices
THURSDAY, May 3, 2018 -- Lightning, which can result in strong electromagnetic fields (EMFs), can interfere with deep brain stimulation (DBS) devices, according to a case report published online May 1 in the Journal of Neurosurgery. Noting that DBS... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 3, 2018 Category: Pharmaceuticals Source Type: news

FDA Clears Deep-Brain Stimulation Device for Resistant Epilepsy FDA Clears Deep-Brain Stimulation Device for Resistant Epilepsy
The FDA has granted premarket approval for Medtronic's deep-brain stimulation therapy as adjunctive treatment for seizure reduction in adults with refractory epilepsy, the company announced.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 1, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news

Medtronic wins FDA PMA for DBS epilepsy treatment
Medtronic (NYSE:MDT) said today it won FDA premarket approval for its Deep Brain Stimulation therapy, indicated as an adjunctive treatment for reducing the frequency of partial-onset seizures. The DBS treatment is cleared for patients 18 years or older who are refractory or drug resistant to three or more antiepileptic medications, the Fridley, Minn.-based company said. Medtronic’s DBS therapy functions through the delivery of controlled electrical pulses to the anterior nucleus of the thalamus which is part of a network involved in seizures, the company said. Approval came based on seven years of data from the ...
Source: Mass Device - May 1, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Neurological Neuromodulation/Neurostimulation Pre-Market Approval (PMA) Regulatory/Compliance Medtronic Source Type: news

Lightning carries potential danger to people with deep brain stimulators
(Journal of Neurosurgery Publishing Group) Patients receiving deep brain stimulation are warned that their neurostimulators may dysfunction when confronted by electromagnetic fields generated by particular electrical devices found at work, home, and in the hospital. A new and potentially dangerous source of dysfunction has been identified: nearby lightening. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 1, 2018 Category: Biology Source Type: news

Unilateral DBS Reduces Axial Essential Tremor Unilateral DBS Reduces Axial Essential Tremor
With greater potential for side effects associated with bilateral deep-brain stimulation, does starting with a unilateral procedure make sense for treating axial essential tremor?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 27, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Boston Sci Sees Strong Data From Parkinson & #039;s Treatment Study
This study meets a new level of rigor in evaluating the effectiveness of a DBS system," Jerrold Vitek, MD, Phd, McKnight professor and chair, Department of Neurology, University of Minnesota Medical School and coordinating principal investigator for the INTREPID study, said in a release. "The double-blind design gives us confidence that the improvements in patients on time with good symptom control, as evaluated by the diary data, are an objective measure of the outcomes and suggests patients will benefit from the Vercise System." Boston Scientific received FDA approval for Vercise late last year. The device...
Source: MDDI - April 24, 2018 Category: Medical Devices Authors: Omar Ford Tags: Implants Source Type: news

Boston Scientific touts 1-year data on Vercise DBS in Parkinson ’ s
This study meets a new level of rigor in evaluating the effectiveness of a DBS system,” coordinating principal investigator Dr. Jerrold Vitek, of the University of Minnesota Medical School, said in prepared remarks. “The double-blind design gives us confidence that the improvements in patients on time with good symptom control, as evaluated by the diary data, are an objective measure of the outcomes and suggests patients will benefit from the Vercise System.” Vercise won CE Mark approval in the European Union to treat essential tremor in 2014. FDA approval to treat Parkinson’s followed las...
Source: Mass Device - April 24, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Neuromodulation/Neurostimulation Boston Scientific Parkinson's disease Source Type: news

Boston Scientific Announces Positive Late-Breaking Data From The INTREPID Study
MARLBOROUGH, Mass., April 24, 2018 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) today announced one-year data from the INTREPID study, the first and only prospective, double-blind, randomized, sham-controlled, mul... Devices, Neurology Boston Scientific, INTREPID study, deep brain stimulation, Parkinson's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2018 Category: Pharmaceuticals Source Type: news

The feasibility and positive effects of a customised videogame rehabilitation programme for freezing of gait and falls in Parkinson's disease patients: a pilot study - Nuic D, Vinti M, Karachi C, Foulon P, Van Hamme A, Welter ML.
BACKGROUND: Freezing of gait and falls represent a major burden in patients with advanced forms of Parkinson's disease (PD). These axial motor signs are not fully alleviated by drug treatment or deep-brain stimulation. Recently, virtual reality has emerged... (Source: SafetyLit)
Source: SafetyLit - April 16, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Could BioSig Play a Vital Role in the Bioelectronics Market?
BioSig Technologies is hoping to make an impact in the $4.6 billion electrophysiology (EP) market with its first product offering. The Santa Monica, CA-based company is developing the Pure EP system, a surface electrocardiogram and intracardiac multichannel device. BioSig filed said it filed for FDA clearance of the Pure EP system in late March. Once the company receives FDA clearance then it would turn its attention toward gaining regulatory clearance in Europe. “We feel like we’ve made a very robust submission to FDA,” Ken Londoner, founder and CEO of BioSig, told MD+DI. The Pure EP Syste...
Source: MDDI - April 6, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Digital Health Source Type: news

Neuroscientists develop potential tools for the study of brain function
(University of Missouri-Columbia) A team of University of Missouri neuroscientists are inching closer to developing the tools needed to decipher the brain. Now, the team has published a new paper that demonstrates how these proteins can be used as tools to regulate the activity of individual neurons in the brain through changes in temperature. These tools will advance fundamental brain research and potentially lead to 'deep brain stimulation' treatments used for Alzheimer's and Parkinson's patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 21, 2018 Category: International Medicine & Public Health Source Type: news

Near-infrared deep brain stimulation via upconversion nanoparticle-mediated optogenetics
Optogenetics has revolutionized the experimental interrogation of neural circuits and holds promise for the treatment of neurological disorders. It is limited, however, because visible light cannot penetrate deep inside brain tissue. Upconversion nanoparticles (UCNPs) absorb tissue-penetrating near-infrared (NIR) light and emit wavelength-specific visible light. Here, we demonstrate that molecularly tailored UCNPs can serve as optogenetic actuators of transcranial NIR light to stimulate deep brain neurons. Transcranial NIR UCNP-mediated optogenetics evoked dopamine release from genetically tagged neurons in the ventral teg...
Source: ScienceNOW - February 8, 2018 Category: Science Authors: Chen, S., Weitemier, A. Z., Zeng, X., He, L., Wang, X., Tao, Y., Huang, A. J. Y., Hashimotodani, Y., Kano, M., Iwasaki, H., Parajuli, L. K., Okabe, S., Teh, D. B. L., All, A. H., Tsutsui-Kimura, I., Tanaka, K. F., Liu, X., McHugh, T. J. Tags: Materials Science, Neuroscience reports Source Type: news

Deep brain stimulation -- A new treatment approach in patients with multiple sclerosis
(Charit é - Universit ä tsmedizin Berlin) A pilot study conducted by researchers from Charit é 's NeuroCure Cluster of Excellence has shown that treatment with deep transcranial magnetic stimulation (dTMS) significantly reduces symptoms of fatigue in patients with multiple sclerosis (MS). Published in the current issue of the journal Neurology: Neuroimmunology& Neuroinflammation*, results from this research suggest that TMS is a safe option for the treatment of patients with MS. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 7, 2018 Category: International Medicine & Public Health Source Type: news

Deep Brain Stimulation May Slow Alzheimer's Deep Brain Stimulation May Slow Alzheimer's
Research into DBS for Alzheimer's has focused on brain regions involved in memory. A new study shows using it in frontal behavioral and cognitive neural networks may slow decline in executive function.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 6, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Asleep Deep Brain Stimulation as Effective as Awake Asleep Deep Brain Stimulation as Effective as Awake
Medscape speaks with the authors of a recent study in Parkinson disease, whose results may lead more patients to seek out this effective but underused therapy.Medscape Neurology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 5, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Expert Interview Source Type: news

Deep Brain Stimulation May Be Promising Alzheimer ’ s Treatment
DBS at ventral capsule/ventral striatum linked to less decline on Clinical Dementia Rating - Sum of Boxes (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - February 1, 2018 Category: Psychiatry Tags: Neurology, Psychiatry, Journal, Source Type: news

Medical News Today: Alzheimer's: Brain implant could improve cognitive function
Is deep brain stimulation a way forward in treating Alzheimer's disease? A phase I clinical trial suggests that it can improve cognitive functioning. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 31, 2018 Category: Consumer Health News Tags: Alzheimer's / Dementia Source Type: news

Deep-Brain Stimulation Improves Tourette's Tics Deep-Brain Stimulation Improves Tourette's Tics
Deep-brain stimulation significantly improves tics associated with Tourette's syndrome, a new registry-based study suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 18, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Brain Zaps May Help Curb Tics of Tourette Syndrome
The procedure, called deep brain stimulation (DBS), improved tic severity by nearly half in 171 patients with uncontrolled Tourette symptoms at 31 hospitals in 10 countries. (Source: WebMD Health)
Source: WebMD Health - January 16, 2018 Category: Consumer Health News Source Type: news

Brain Zaps May Help Curb Tics of Tourette Syndrome
TUESDAY, Jan. 16, 2018 -- Electric zaps can help rewire the brains of Tourette syndrome patients, effectively reducing their uncontrollable vocal and motor tics, a new study shows. The procedure, called deep brain stimulation (DBS), improved tic... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 16, 2018 Category: General Medicine Source Type: news

Boston Scientific shares jump on prelim Q4, FY2017 earnings
Boston Scientific (NYSE:BSX) shares have seen a significant bump today after the company released preliminary fourth quarter and fiscal year 2017 earnings that topped The Street and showed growth of approximately 9.9% and 7.9%, respectively. For the fourth quarter, the Marlborough, Mass.-based company said it expects to report sales of $2.4 billion, just in line with the approximate $2.4 billion consensus on Wall Street. The quarterly results represent 9.9% growth on a reported basis, 8.1% on an operational basis and approximately 6.8% on an organic basis, the company said in a press release. For the full year, Boston...
Source: Mass Device - January 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Wall Street Beat Boston Scientific Source Type: news

Deep brain stimulation: Improving outcomes in the treatment of movement disorders
(Charit é - Universit ä tsmedizin Berlin) For the first time, researchers from Charit é have shown that, in patients with a type of movement disorder known as dystonia, a particular pattern of brain activity is linked to both the severity of symptoms and the clinical outcomes achieved through deep brain stimulation. Results from this study, which has been published in the journal Annals of Neurology*, may help to improve the way in which treatment is adapted to an individual patients needs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 22, 2017 Category: International Medicine & Public Health Source Type: news

Deep brain stimulation linked to longer survival for Parkinson's patients
(Veterans Affairs Research Communications) A treatment called deep brain stimulation could slightly extend the life of people with Parkinson's disease. Veterans Affairs researchers found that patients who received stimulation via an implanted device had a modest survival advantage compared with those treated with medication only. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 21, 2017 Category: International Medicine & Public Health Source Type: news

Deep-Brain Stimulation May Be Safe in Parkinson's Dementia Deep-Brain Stimulation May Be Safe in Parkinson's Dementia
Cognition did not improve in a preliminary study targeting a novel area of the brain, but there did appear to be benefits on other Parkinson's symptoms, particularly hallucinations.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 20, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Can A Zap to the Brain Recharge Your Memory?
Carefully targeted deep brain stimulation might one day enhance long-term memory, a small study suggests. (Source: WebMD Health)
Source: WebMD Health - December 19, 2017 Category: Consumer Health News Source Type: news

Could an Electric Pulse to the Brain Recharge Your Memory?
TUESDAY, Dec. 19, 2017 -- Carefully targeted deep brain stimulation might one day enhance long-term memory, a small study suggests. The experiment involved just 14 epilepsy patients, all of whom had undergone an invasive procedure to insert... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 19, 2017 Category: General Medicine Source Type: news

Elekta taps Brainlab as US stereotactic neurosurgery distro partner
Elekta (STO:EKTA B) said today it inked an exclusive deal with Brainlab to make it the authorized distributor of Elekta’s stereotactic neurosurgery solutions. Through the deal, Brainlab will be the authorized distributor of Elekta’s Leksell Vantage stereotactic system which won CE Mark approval in the European Union this year. The system also has FDA 510(k) clearance and is commercially available in the US. Stereotactic neurosurgery is a minimally invasive approach to brain surgery designed to treat specific regions of the brain and spare surrounding healthy tissue, and is often used to implant deep brain ...
Source: Mass Device - December 13, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Distribution Neurological Brainlab Elekta Source Type: news

Here & #039;s the Secret Behind Boston Scientific & #039;s New DBS Device
Unlike traditional deep brain stimulation (DBS) systems that are built from pacemaker technology, Boston Scientific's Vercise DBS is modeled from cochlear implant technology and the precise stimulation of auditory nerves it uses to replicate hearing. The device is now FDA approved for the treatment of Parkinson's disease symptoms, the company announced this week. "The cochlear implant technology, when you think about it, is really designed and engineered to precisely stimulate the auditory nerves to produce a sense of hearing," Maulik Nanavaty, a senior vice president at Boston Scientific and president of th...
Source: MDDI - December 12, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Implants Source Type: news

FDA Clears Deep-Brain Stimulation System for Parkinson's FDA Clears Deep-Brain Stimulation System for Parkinson's
The Vercise implantable pulse generator is the smallest rechargeable DBS device available in the United States and, depending on individual use, can have a battery life of more than 15 years.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 12, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news

Boston Scientific wins FDA nod for Vercise DBS for treating Parkinson ’ s disease
Boston Scientific (NYSE:BSX) said yesterday it won FDA approval for its Vercise deep brain stimulation system designed to treat symptoms of Parkinson’s disease. The device, initially launched in Europe in 2012, was developed based on cochlear implant technology and is designed to stimulate a targeted region of the brain through implanted leads powered by an implantable pulse generator.  The device also has the ability to independently control the amount of current delivered on each lead, the company said. “This approval marks an important step for patients who will now have the choice to be treat...
Source: Mass Device - December 12, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Neuromodulation/Neurostimulation Regulatory/Compliance Boston Scientific Source Type: news

Boston Scientific shares rise on U.S. approval for Parkinson ’s disease treatment
Boston Scientific Corp. announced U.S. regulators have approved its Vercise Deep Brain Stimulation System to treat patients with Parkinson ’s disease Monday, boosting its share price nearly 3 percent in after-hours trading. The device, which stimulates a specific area of the brain using implanted leads, was shown in a U.S. trial to help improve the number of waking hours per day in patients with the disease, according to the company . In another study in Europe, it helped patients achieve a 63 percent… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 12, 2017 Category: Pharmaceuticals Authors: Don Seiffert Source Type: news

DBS Falls Short for Treatment-Resistant Depression DBS Falls Short for Treatment-Resistant Depression
Deep brain stimulation (DBS) proves disappointing in long-standing, treatment-resistant depression at 1-year follow-up.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 8, 2017 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Science News » NIH Announces Awards for BRAIN Initiative Neuroethics Research
The NIH BRAIN Initiative has awarded grants to five teams of experts who will study the neuroethical issues surrounding the use of deep brain stimulation in neuropsychiatric and movement disorders and appropriate consent for brain research. (Source: National Institute of Mental Health)
Source: National Institute of Mental Health - November 6, 2017 Category: Psychiatry Authors: Barbara McMakin Source Type: news

OHSU study validates deep brain surgery while asleep for Parkinson's patients
Most brain surgeons in the U.S. perform the procedure with patients awake the whole time. Not at OHSU.Most surgeons perform deep brain stimulation to ease the effects of Parkinson ’s disease while the patient is awake. Not at Oregon Health& Science University. OHSU neurologists stopped doing awake surgeries in January 2011. They pioneered a technique to accurately map the brain before and during the procedure, allowing the patient to remain asleep with general anesthesia all the while. With DBS, surgeons implant electrodes into specific areas of the brain that control movement in order to improve motor function a...
Source: bizjournals.com Health Care News Headlines - November 3, 2017 Category: Health Management Authors: Elizabeth Hayes Source Type: news

OHSU study validates deep brain surgery while asleep for Parkinson's patients
Most brain surgeons in the U.S. perform the procedure with patients awake the whole time. Not at OHSU.Most surgeons perform deep brain stimulation to ease the effects of Parkinson ’s disease while the patient is awake. Not at Oregon Health& Science University. OHSU neurologists stopped doing awake surgeries in January 2011. They pioneered a technique to accurately map the brain before and during the procedure, allowing the patient to remain asleep with general anesthesia all the while. With DBS, surgeons implant electrodes into specific areas of the brain that control movement in order to improve motor function a...
Source: bizjournals.com Health Care:Biotechnology headlines - November 3, 2017 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Abbott launches Proclaim DRG neurostim
Abbott (NYSE:ABT) said today it launched its Proclaim dorsal root ganglion neurostimulator system designed to treat pain in patients with complex regional pain syndrome of the lower limbs. The company’s Proclaim DRG system is designed to be used via Bluetooth with an Apple (NSDQ:AAPL) iPod touch as a system controller and is magnetic resonance-conditional and recharge free, all upgrades from previous versions of the device, the Abbott Park, Ill.-based company said. Abbott said it originally launched the DRG therapy system in 2016 and data from the Accurate study of it showed the system delivers “...
Source: Mass Device - October 16, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Neuromodulation/Neurostimulation Pain Management Abbott Source Type: news

MassDevice.com +5 | The top 5 medtech stories for October 13, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. 10 tips for selecting and managing a medtech development partner There many things to consider when searching for and interacting with a product development firm – and the stakes are high! Most early-stage medical device ...
Source: Mass Device - October 13, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Abbott study shows promise for DBS therapy for treatment-resistant depression
This study is a strong example of how our therapies can contribute to the innovation taking place within the broad field of neuroscience. We applaud the researchers who led this study and look forward to future advancements to support the care of people suffering from chronic, treatment-resistant depression,” Abbott neuromod division medical director Dr. Allen Burton said in a prepared statement. Abbott said that currently its DBS system is only indicated for treating essential tremor and Parkinson’s disease. Earlier this month, Abbott closed its $5.3 billion buy of diagnostics giant Alere (NYSE:ALR),...
Source: Mass Device - October 13, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Neuromodulation/Neurostimulation Abbott Source Type: news

New Data Shows That For Some Patients, Deep Brain Stimulation May Address Chronic Depression
- A new dataset published in The Lancet: Psychiatry highlights the largest prospective study in DBS for chronic, treatment-resistant depression (Source: Abbott.com)
Source: Abbott.com - October 11, 2017 Category: Pharmaceuticals Source Type: news

Deep brain stimulation helps Parkinson ’s patients regain independence
New technology called deep brain stimulation may offer an alternative to conventional treatment of patients with Parkinson ’s disease. (Source: Yale Science and Health News)
Source: Yale Science and Health News - September 21, 2017 Category: Universities & Medical Training Source Type: news

Intermittent electrical brain stimulation improves memory
(Medical College of Georgia at Augusta University) Intermittent electrical stimulation of an area deep inside the brain that degenerates in Alzheimer's appears to improve working memory, scientists report.Conversely, continuous deep brain stimulation, like the type used for Parkinson's and currently under study in humans with Alzheimer's, impairs memory, according to study results in adult non-human primates reported in the journal Current Biology. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 7, 2017 Category: International Medicine & Public Health Source Type: news

Deep Brain Stimulation May Offer Hope for Severe Schizophrenia Deep Brain Stimulation May Offer Hope for Severe Schizophrenia
Patients with treatment-resistant schizophrenia may benefit from deep brain stimulation, although the surgical risks need to be considered, say Spanish researchers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 5, 2017 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Rush testing if genetic clues identify best candidates for Parkinson's surgery
(Rush University Medical Center) A new clinical trial is testing whether a common genetic mutation makes Parkinson's Disease patients more likely to suffer cognitive decline after deep brain stimulation surgery. This information would help neurologists identify the best candidates for this procedure and targets different brain areas based on that genetic information. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 31, 2017 Category: International Medicine & Public Health Source Type: news

Driving ability in Parkinson's disease - Buhmann C, Vesper J, Oelsner H.
About 60 % of all patients with Parkinson's disease (PD) and about 50 % of PD patients with deep brain stimulation (DBS) in possession of a driving license are active car-drivers. Parkinson patients, however, often display physical and/or psychological wea... (Source: SafetyLit)
Source: SafetyLit - August 17, 2017 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Mayo Clinic picks up 11% stake in neuromod startup NeuroOne
The Mayo Clinic as acquired an 10.9% stake in epilepsy treatment neuromod startup NeuroOne’s parent firm, according an SEC filing from the company. NeuroOne is developing a “thin film” electrode technology, originally from the University of Wisconsin, designed to be implanted in the brain. The film can detect irregular brain activity, accurate to single neurons, to pinpoint the source of seizures and tremors, according to the filing, and has been used in testing at the Mayo Clinic. The technology combines detection alongside deep brain stimulation treatment and ablation capabilities to monitor and treat i...
Source: Mass Device - August 7, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Neurological Neuromodulation/Neurostimulation Mayo Clinic neuroone Source Type: news

Researchers make steps towards closed-loop DBS system for essential tremor, Parkinsons
Researchers at the University of Washington say they developed an advanced deep brain stimulation system designed to treat essential tremor without constantly being “on,” allowing for longer battery life and better treatment. The system utilizes electrodes on top of the brain to sense movement in parts of the body that experience essential tremor, alongside a deep brain electrode to deliver stimulation only when it’s needed. Previous versions of deep brain stimulation systems delivered treatment at all times, with no way to turn the system off, even while the patient is asleep. Read the whole story on our...
Source: Mass Device - June 28, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Neurological Neuromodulation/Neurostimulation Medtronic Source Type: news